Ablative Solutions
PrivateLast Round
Growth Equity
Nov 14, 2025
Total Funding Raised
$155.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ablative Solutions operates in Healthcare & Life Sciences and is based in Wakefield, Massachusetts. Its latest recorded funding round was a Series D round in December 2024.
Ablative Solutions is a medical device company that develops catheter-based neurolytic delivery systems for the treatment of uncontrolled hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablative Solutions Comparables
Compare Ablative Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vascular Dynamics, Inc. | 84% | |
| Symple Surgical | 82% | |
| DeepQure | 82% |
For institutional investors. Book with your work email.
Ablative Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Nov 14, 2025 | ||||
| Series D | Dec 26, 2024 | ||||
| Early Stage VC | Mar 31, 2023 | ||||
| Series D | Jun 13, 2022 | ||||
| Series C | Jan 3, 2018 | ||||
Series B | Feb 4, 2014 |
For institutional investors. Book with your work email.
Ablative Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioStar Equity | Series B, Series A |
| Gilde Healthcare | Series D |
| Invus Opportunities | Series D |
| Charter Capital Partners | Series D, Series B, Series A |
| BioStar Capital | Series A, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
$10.4M round raised
- Dec 26, 2024
$45.5M raised in Series D financing.
For institutional investors. Book with your work email.
Ablative Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ablative Solutions's valuation, stock price, and market status.
Is Ablative Solutions a public or private company?
Ablative Solutions is a private company.
What is the current stock price of Ablative Solutions?
Ablative Solutions is a private company, so its shares have no public market price. Caplight tracks Ablative Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ablative Solutions worth (valuation)?
Valuation information for Ablative Solutions is not publicly available.
Can I buy Ablative Solutions stock?
Ablative Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ablative Solutions's last funding round?
Ablative Solutions's most recent funding round was Growth Equity on November 14, 2025.
Who are the main investors in Ablative Solutions?
Key investors in Ablative Solutions include BioStar Equity, Gilde Healthcare, Invus Opportunities, BioStar Capital.
Will Ablative Solutions IPO soon?
No public IPO plans have been announced for Ablative Solutions.
How can I track Ablative Solutions secondary market activity?
Caplight tracks bids, offers, and trades in Ablative Solutions's shares on secondary markets.